David Thomas McGreevy

David Thomas McGreevy

Auto-generated profile, based on publicly available information

David Thomas McGreevy

Department of Cardiothoracic and Vascular Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2020 in World Journal of Emergency Surgery
Verified
Journal Article
Open access
PDF file
TGthe ABOTrauma Registry research group
the ABOTrauma Registry research group
PHPeter Hilbert-Carius
Peter Hilbert-Carius
DMDavid T. McGreevy
David T. McGreevy
FAFikri M. Abu-Zidan
Fikri M. Abu-Zidan
THTal M. Hörer
Tal M. Hörer
Background: Severely injured trauma patients suffering from traumatic cardiac arrest (TCA) and requiring cardiopulmonary resuscitation (CPR) rarely survive. The role of resuscitative endovascular balloon occlusion of the aorta (REBOA) performed early after hospital admission in patients with TCA is not well-defined. As the use of REBOA increases, there is great interest in knowing if there is a survival benefit related to the early use of REBOA after TCA. Using data from the ABOTrauma Registry, we aimed to study the role of REBOA used early after hospital admission in trauma patients who required pre-hospital CPR.Methods: Retrospective and prospective data on the use of REBOA were collected from the ABOTrauma Registry from 11 centers in seven countries globally between 2014 and 2019. In all patients with pre-hospital TCA, the predicted probability of survival, calculated with the Revised Injury Severity Classification II (RISC II), was compared with the observed survival rate.Results: Of 213 patients in the ABOTrauma Registry, 26 patients (12.2%) who had received pre-hospital CPR were identified. The median (range) Injury Severity Score (ISS) was 45.5 (25–75). Fourteen patients (54%) had been admitted to the hospital with ongoing CPR. Nine patients (35%) died within the first 24 h, while seventeen patients (65%) survived post 24 h. The survival rate to hospital discharge was 27% (n= 7). The predicted mortality using the RISC II was 0.977 (25 out of 26). The observed mortality (19 out of 26) was significantly lower than the predicted mortality (p= 0.049). Patients not responding to REBOA were more likely to die. Only one (10%) out of 10 non-responders survived. The survival rate in the 16 patients responding to REBOA was 37.5% (n= 6). REBOA with a median (range) duration of 45 (8–70) minutes significantly increases blood pressure from the median (range) 56.5 (0–147) to 90 (0–200) mmHg.Conclusions: Mortality in patients suffering from TCA and receiving REBOA early after hospital admission is significantly lower than predicted by the RISC II. REBOA may improve survival after TCA. The use of REBOA in these patients should be further investigated.

16 December 2019 in Shock
Verified
Journal Article
Closed access
DMDavid Thomas McGreevy
David Thomas McGreevy
FAFikri M. Abu-Zidan
Fikri M. Abu-Zidan
MSMitra Sadeghi
Mitra Sadeghi
APArtai Pirouzram
Artai Pirouzram
ATAsko Toivola
Asko Toivola
THTal Martin Hörer
Tal Martin Hörer
Background: Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) may improve Systolic Blood Pressure (SBP) in hypovolemic shock. It has, however, not been studied in patients with impending traumatic cardiac arrest (ITCA). We aimed to study the feasibility and clinical outcome of REBOA in patients with ITCA using data from the ABOTrauma Registry. Methods: Retrospective and prospective data on the use of REBOA from 16 centers globally were collected. SBP was measured both at pre- and post-REBOA inflation. Data collected included patients’ demography, vascular access technique, number of attempts, catheter size, operator, zone and duration of occlusion, and clinical outcome. Results: There were 74 patients in this high-risk patient group. REBOA was performed on all patients. A 7-10Fr catheter was used in 66.7% and 58.5% were placed on the first attempt, 52.1% through blind insertion and 93.2% inflated in Zone I, 64.8% for a period of 30 to 60 min, 82.1% by ER doctors, trauma surgeons, or vascular surgeons. SBP significantly improved to 90 mm Hg following the inflation of REBOA. 36.6% of the patients survived. Conclusions: Our study has shown that REBOA may be performed in patients with ITCA, SBP can be elevated, and 36.6% of the patients survived if REBOA placement is successful.

4 March 2020 in Updates in Surgery
Verified
Journal Article
Closed access
PDF file
ACand Federico Coccolini
and Federico Coccolini
MCMarco Ceresoli
Marco Ceresoli
DMDavid T. McGreevy
David T. McGreevy
MSMitra Sadeghi
Mitra Sadeghi
APArtai Pirouzram
Artai Pirouzram
THTal M. Hörer
Tal M. Hörer

1 December 2020 in Journal of Surgical Research
Verified
Journal Article
Closed access
JHJustin S. Hatchimonji
Justin S. Hatchimonji
ACAmanda M. Chipman
Amanda M. Chipman
DMDavid T. McGreevy
David T. McGreevy
THTal M. Hörer
Tal M. Hörer
SBSigrid Burruss
Sigrid Burruss
JCJeremy W. Cannon
Jeremy W. Cannon

28 October 2022 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
DMDavid T. McGreevy
David T. McGreevy
APArtai Pirouzram
Artai Pirouzram
KGKhatereh Djavani Gidlund
Khatereh Djavani Gidlund
KNKristofer F. Nilsson
Kristofer F. Nilsson
THTal M. Hörer
Tal M. Hörer

30 January 2021 in European Journal of Trauma and Emergency Surgery
Verified
Journal Article
Open access
PDF file
DMDavid T. McGreevy
David T. McGreevy
MSMitra Sadeghi
Mitra Sadeghi
KNKristofer F. Nilsson
Kristofer F. Nilsson
THTal M. Hörer
Tal M. Hörer
Background: Hemodynamic instability due to torso hemorrhage can be managed with the assistance of resuscitative endovascular balloon occlusion of the aorta (REBOA). This is a report of a single-center experience using the ER-REBOA™ catheter for traumatic and non-traumatic cases as an adjunct to hemorrhage control and as part of the EndoVascular resuscitation and Trauma Management (EVTM) concept. The objective of this report is to describe the clinical usage, technical success, results, complications and outcomes of the ER-REBOA™ catheter at Örebro University hospital, a middle-sized university hospital in Europe.Methods: Data concerning patients receiving the ER-REBOA™ catheter for any type of hemorrhagic shock and hemodynamic instability at Örebro University hospital in Sweden were collected prospectively from October 2015 to May 2020.Results: A total of 24 patients received the ER-REBOA™ catheter (with the intention to use) for traumatic and non-traumatic hemodynamic control; it was used in 22 patients. REBOA was performed or supervised by vascular surgeons using 7–8 Fr sheaths with an anatomic landmark or ultrasound guidance. Systolic blood pressure (SBP) increased significantly from 50 mmHg (0–63) to 95 mmHg (70–121) post REBOA. In this cohort, distal embolization and balloon rupture due to atherosclerosis were reported in one patient and two patients developed renal failure. There were no cases of balloon migration. Overall 30-day survival was 59%, with 45% for trauma patients and 73% for non-traumatic patients. Responders to REBOA had a significantly lower rate of mortality at both 24 h and 30 days.Conclusions: Our clinical data and experience show that the ER-REBOA™ catheter can be used for control of hemodynamic instability and to significantly increase SBP in both traumatic and non-traumatic cases, with relatively few complications. Responders to REBOA have a significantly lower rate of mortality.